3rd party tested bpc-157 Peptide Therapy Tissue Recovery Research Archives -
Description
The GHK-Cu also increased superoxide dismutase (SOD) activity while decreasing TNF-1 and IL-6 production through the blocking activation of NFBs p65 and p38 MAPK (mitogen activated protein kinase)
Yeah, I'll find out from him
After reviewing their protocol, the cause became clear
J Orthop Res 21(6):976983
This is precisely where peptides enter the picture
